The patient completed a course of vancomycin for methicillin-resistant Staphylococcus aureus pneumonia.
His amiodarone dose was titrated down to 200 mg q.d.
They did not feel that there was need for pacemaker for bradycardia at this time, but rather suggested that the patient's amiodarone be decreased to 200 mg q.d.
He had several follow-up electrocardiograms that continued to show sinus rhythm with left axis deviation, intraventricular conduction delay, left ventricular hypertrophy by voltage, and ST depressions in V2 and V3 that were unchanged when compared to previous electrocardiograms.
RENAL:  From a renal standpoint, the patient was continued on hemodialysis through a tunnel Perm-A-Cath.
Nephrology followed the patient while in the hospital, and the decision was made that the patient would be discharged on hemodialysis through his tunnel catheter and would have both Renal followup and followup in Transplant Surgery Clinic for a possible arteriovenous fistula placement.
INFECTIOUS DISEASE:  From an infectious disease standpoint, the patient completed a course of vancomycin for methicillin-resistant Staphylococcus aureus pneumonia.
On the floor he was continued on a regular insulin sliding-scale and NPH regimen with very good glycemic control.
HEMATOLOGY:  From a hematologic standpoint, the patient had received a total of 5 units of packed red blood cells and had been started on Epogen with a very stable hematocrit throughout his hospitalization.
PSYCHOSOCIAL:  From a psychosocial standpoint, the patient continued to evidence a reluctance to participate in his recovery; refusing to wear BiPAP for his sleep apnea and refusing to work with Occupational Therapy and Physical Therapy.
The patient had already been started on Paxil for depression, and it was felt that his attitude was most likely secondary to his medical condition.
FLUIDS/ELECTROLYTES/NUTRITION:  From a fluids, electrolytes, and nutrition standpoint the patient was continued on tube feeds and began to take food orally during the last few days of admission.
The patient was arranged to have an evaluation for arteriovenous fistula placement in the Transplant Surgery Clinic with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] on [**2150-1-15**], at 2:30 p.m.
Enteric-coated aspirin 325 mg p.o.
Plavix 75 mg p.o.
Paxil 20 mg p.o.
Nepro tube feeds (goal 75 cc per hour).
Tums 500 mg p.o.
Digoxin 0.125 mg p.o.
post dialysis only.
Captopril 37.5 mg p.o.
Reglan 5 mg p.o.
Lipitor 40 mg p.o.
NPH insulin 10 units subcutaneous q.a.m.
Epogen 5000 units intravenous three times per week by dialysis nurse.
Miconazole powder applied to affected areas b.i.d.
Amiodarone 200 mg p.o.
Colace 100 mg p.o.
Ativan 0.5 mg to 1 mg intravenously q.4h.
Tylenol 650 mg p.o.
Oxycodone 5 mg to 10 mg p.o.
Prevacid elixir 30 mg p.o.
He should wear BiPAP at night for obstructive sleep apnea.
Coronary artery disease, status post myocardial infarction.
